Cargando…
2’,3’ cyclic-nucleotide 3’-phosphodiesterase (CNP) inhibits SARS-CoV-2 virion assembly by blocking infection-induced mitochondria depolarization
The COVID-19 pandemic has claimed over 6.5 million lives worldwide and continues to have lasting impacts on the world’s healthcare and economic systems. Several approved and emergency authorized therapeutics that inhibit early stages of the virus replication cycle have been developed however, effect...
Autores principales: | Logue, James, Melville, Victoria M., Ardanuy, Jeremy, Frieman, Matthew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274905/ https://www.ncbi.nlm.nih.gov/pubmed/37333151 http://dx.doi.org/10.1101/2023.06.09.544327 |
Ejemplares similares
-
CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2
por: Cachorro, Eleder, et al.
Publicado: (2023) -
2’,3’-Cyclic Nucleotide 3’-Phosphodiesterases Inhibit Hepatitis B Virus Replication
por: Ma, Hui, et al.
Publicado: (2013) -
The Functions of Mitochondrial 2′,3′-Cyclic Nucleotide-3′-Phosphodiesterase and Prospects for Its Future
por: Olga, Krestinina, et al.
Publicado: (2020) -
Myelin 2′,3′-Cyclic Nucleotide 3′-Phosphodiesterase: Active-Site Ligand Binding and Molecular Conformation
por: Myllykoski, Matti, et al.
Publicado: (2012) -
Determinants of ligand binding and catalytic activity in the myelin enzyme 2′,3′-cyclic nucleotide 3′-phosphodiesterase
por: Raasakka, Arne, et al.
Publicado: (2015)